clinical trial · NCT00092651
A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)
Organon and Co·phase3·completed·n = 1,398
HypercholesterolemiaMK0653A, ezetimibe (+) simvastatinComparators: simvastatin and ezetimibe
brief summary
The purpose of this study is to evaluate the lipid lowering effects of an investigational drug in patients with hypercholesterolemia (high cholesterol).
started
Sep 1, 2002
primary completion
Jun 1, 2003
completion
Jun 1, 2003
last updated
Aug 23, 2024
detailed description
The duration of treatment is 4 months.
official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, "Factorial" Design Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet in Patients With Primary Hypercholesterolemia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol